Reading between the (Genetic) Lines: How Epigenetics is Unlocking Novel Therapies for Type 1 Diabetes
<p dir="ltr">Type 1 diabetes (T1D) is an autoimmune condition where the body’s immune cells destroy their insulin-producing pancreatic beta cells leading to dysregulated glycaemia. Individuals with T1D control their blood glucose through exogenous insulin replacement therapy, often u...
محفوظ في:
| المؤلف الرئيسي: | Ammira-Sarah AL-Shabeeb Akil (18949477) (author) |
|---|---|
| مؤلفون آخرون: | Laila F. Jerman (18949480) (author), Esraa Yassin (11618606) (author), Sujitha S. Padmajeya (14152698) (author), Alya Al-Kurbi (18543970) (author), Khalid A. Fakhro (3158862) (author) |
| منشور في: |
2020
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
Beyond genetics: Exploring the role of epigenetic alterations in breast cancer
حسب: Kirti S. Prabhu (4246144)
منشور في: (2024) -
Role of Epigenetic Modifications in Inhibitory Immune Checkpoints in Cancer Development and Progression
حسب: Reem Saleh (3513056)
منشور في: (2020) -
Epigenetic Regulations of Cancer Stem Cells by the Aryl Hydrocarbon Receptor Pathway
حسب: Sabah, Akhtar
منشور في: (2020) -
Epigenetic and breast cancer therapy: Promising diagnostic and therapeutic applications
حسب: Gulab Sher (12984698)
منشور في: (2022) -
Epigenetic regulation of CXCR4 signaling in cancer pathogenesis and progression
حسب: Reem Khaled M.E., Alsayed
منشور في: (2022)